ZEB2 and neoplasm: Additionally, expression levels of the downstream markers ZEB-2 and RAB-14 were downregulated, while those of the tumor suppressors CDKN2A, P63, and SIRT-1 were upregulated in the non-tumor specimens of LC patients with underlying respiratory disease compared to non-COPD patients.